ACLARIS THERAPEUTICS INC's ticker is and the CUSIP is 00461U955. A total of 2 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,559 | +11.5% | 227,700 | +68.8% | 0.00% | 0.0% |
| Q2 2023 | $1,398 | -52.0% | 134,900 | -62.6% | 0.00% | -66.7% |
| Q1 2023 | $2,914 | +97033.3% | 360,300 | +180050.0% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 200 | -88.2% | 0.00% | – |
| Q3 2022 | $26,000 | -66.7% | 1,700 | -69.6% | 0.00% | – |
| Q2 2022 | $78,000 | +169.0% | 5,600 | +229.4% | 0.00% | – |
| Q1 2022 | $29,000 | -3.3% | 1,700 | -19.0% | 0.00% | – |
| Q4 2021 | $30,000 | -91.7% | 2,100 | -90.0% | 0.00% | – |
| Q3 2021 | $361,000 | -1.9% | 21,000 | 0.0% | 0.00% | – |
| Q2 2021 | $368,000 | +3.7% | 21,000 | +14793.6% | 0.00% | -100.0% |
| Q1 2021 | $355,000 | +11733.3% | 141 | +2720.0% | 0.00% | – |
| Q4 2020 | $3,000 | +200.0% | 5 | -16.7% | 0.00% | – |
| Q3 2020 | $1,000 | – | 6 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 6 | -40.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 10 | +900.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 1 | -95.7% | 0.00% | – |
| Q3 2019 | $2,000 | -80.0% | 23 | -50.0% | 0.00% | – |
| Q2 2019 | $10,000 | -16.7% | 46 | +119.0% | 0.00% | – |
| Q1 2019 | $12,000 | – | 21 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 141 | $355,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 11,900 | $300,000 | 0.00% |